New England Research & Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
+10,550
| New | +$1.13M | 0.54% | 65 |
|
|
2021
Q2 | – | Sell |
-7,925
| Closed | -$306K | – | 175 |
|
|
2021
Q1 | $306K | Buy |
7,925
+1,050
| +15% | +$40.5K | 0.17% | 137 |
|
|
2020
Q4 | $247K | Sell |
6,875
-25,663
| -79% | -$922K | 0.15% | 144 |
|
|
2020
Q3 | $1.24M | Buy |
32,538
+1,838
| +6% | +$70.2K | 0.9% | 35 |
|
|
2020
Q2 | $1.08M | Buy |
30,700
+12,350
| +67% | +$434K | 0.77% | 44 |
|
|
2020
Q1 | $599K | Buy |
+18,350
| New | +$599K | 0.51% | 69 |
|
|
2017
Q1 | – | Sell |
-11,550
| Closed | -$250K | – | 165 |
|
|
2016
Q4 | $250K | Buy |
+11,550
| New | +$250K | 0.2% | 150 |
|